News from ACR 2012
November 09 - 14, 2012; Washington, DC
This coverage is not sanctioned by, nor a part of, the ACR.
Top News From ACR 2012: Slideshow
Highlights from the meeting include findings that some rheumatoid arthritis patients may be able to taper biologic therapy,
ustekinumab eases psoriatic arthritis (PSUMMIT II trial), and a novel cathepsin K inhibitor builds bone in older osteoporotic
women.
Medscape Rheumatology©
WebMD, LLC